# US 2003/0225032 A1 · Pharmaceutical composition

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0225032 A1
- Document ID: US20030225032A1
- Status: Published application
- Kind: A1
- Application number: 10/217,551
- Filed: 2002-08-14
- Published: 2003-12-04
- Earliest claimed: 2002-05-28
- Assignees: Taisho Pharmaceutical Co., Ltd.
- Inventors: Shusei Ito; Akio Miwa; Mari Nakano
- Web page: https://patentgrep.com/patent/US20030225032A1

## CPC

- A61K 9/0019: {Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner (non-active ingredients are additionally classified in A61K47/00)}
- A61K 31/5375: 1,4-Oxazines, e.g. morpholine
- A61K 31/724: Cyclodextrins
- A61K 47/40: Cyclodextrins; Derivatives thereof
- A61P 9/00: Drugs for disorders of the cardiovascular system
- A61P 9/10: for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A61P 13/12: of the kidneys
- A61P 25/00: Drugs for disorders of the nervous system
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A61K 9/19: lyophilised {, i.e. freeze-dried, solutions or dispersions (lyophilised products with subsequent particle size reduction A61K9/14; granules or pellets made by lyphilisation A61K9/1682; solid oral dosage forms made by lyophilisation A61K9/2095; lyophilisation additives A61K47/00)}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention provides a pharmaceutical composition comprising N-(3-chloro-4-morpholin-4-yl)phenyl-N′-hydroxyimidoformamidine and sulfobutyl ether β-cyclodextrin or a salt thereof, wherein sulfobutyl ether β-cyclodextrin increases the solubility of N-(3-chloro-4-morpholin-4-yl)phenyl-N′-hydroxyimidoformamidine and improves the photostability.

## Claims

### Claim 1

A pharmaceutical composition which comprises N-(3-chloro-4-morpholin-4-yl)phenyl-N′-hydroxyimidoformamidine and sulfobutyl ether β-cyclodextrin or a salt thereof.

### Claim 2 (depends on 1)

The pharmaceutical composition according to claim 1 which is an injectable solution.

### Claim 3 (depends on 1)

The pharmaceutical composition according to claim 1 which is a freeze-dried injectable preparation.
